EU Horizon grant for NLHI coordinated consortium Geremy

Europe’s research and innovation funding programme Horizon has granted research teams 8M euro funding for the development of new effective therapies for rare diseases. The Netherlands Heart Institute (NLHI) is the coordinator of this consortium, called GEREMY. The goal of this project is to find a cure for inherited arrhythmogenic cardiomyopathy (ACM), a rare cardiac disease.